Published in J Am Acad Orthop Surg on January 01, 2008
The basic science of periprosthetic osteolysis. Instr Course Lect (2001) 1.18
Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles. J Orthop Res (2011) 1.15
Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials (2010) 1.12
Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol (2011) 1.09
Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface (2014) 1.01
Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet (2009) 1.00
Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium. J Biomed Mater Res A (2012) 1.00
Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A (2010) 0.96
The basic science of periprosthetic osteolysis. Instr Course Lect (2013) 0.93
Biological responses of human mesenchymal stem cells to titanium wear debris particles. J Orthop Res (2011) 0.92
Are biologic treatments a potential approach to wear- and corrosion-related problems? Clin Orthop Relat Res (2014) 0.92
Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response. Biomaterials (2013) 0.91
Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation. Bone (2009) 0.91
Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss. Biomaterials (2012) 0.87
Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry. Clin Orthop Relat Res (2015) 0.85
A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation. PLoS One (2013) 0.82
Metallic debris from metal-on-metal total hip arthroplasty regulates periprosthetic tissues. World J Orthop (2014) 0.80
Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles. Tissue Eng Part A (2012) 0.80
Alternative strategies to manipulate fibrocyte involvement in the fibrotic tissue response: pharmacokinetic inhibition and the feasibility of directed-adipogenic differentiation. Acta Biomater (2014) 0.80
Contribution of human osteoblasts and macrophages to bone matrix degradation and proinflammatory cytokine release after exposure to abrasive endoprosthetic wear particles. Mol Med Rep (2016) 0.79
Predictors of osteoclast activity in patients with sickle cell disease. Haematologica (2011) 0.79
Use of kernel-based Bayesian models to predict late osteolysis after hip replacement. J R Soc Interface (2013) 0.78
Biological response to prosthetic debris. World J Orthop (2015) 0.78
Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear? Clin Orthop Relat Res (2014) 0.78
Male gender, Charnley class C, and severity of bone defects predict the risk for aseptic loosening in the cup of ABG I hip arthroplasty. BMC Musculoskelet Disord (2010) 0.78
The Effect of Interferon-γ and Zoledronate Treatment on Alpha-Tricalcium Phosphate/Collagen Sponge-Mediated Bone-Tissue Engineering. Int J Mol Sci (2015) 0.78
Allergy or tolerance: reduced inflammatory cytokine response and concomitant IL-10 production of lymphocytes and monocytes in symptom-free titanium dental implant patients. Biomed Res Int (2013) 0.76
Skin and bones (and cartilage): the dermal fibroblast connection. Nat Rev Rheumatol (2009) 0.75
Cytotoxic effects of cobalt and nickel ions on osteocytes in vitro. J Orthop Surg Res (2014) 0.75
Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. Biomaterials (2016) 0.75
Aging Affects Bone Marrow Macrophage Polarization: Relevance to Bone Healing. Regen Eng Transl Med (2016) 0.75
Joint replacement surgery and the innate immune system. J Long Term Eff Med Implants (2014) 0.75
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18
Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82
Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol (2006) 1.66
Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials (1998) 1.59
Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am (1976) 1.45
Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res (2000) 1.42
The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg Br (2006) 1.38
Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res (1995) 1.35
Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng (2004) 1.34
Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am (1995) 1.22
Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res (2001) 1.21
Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res (2005) 1.14
Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum (1986) 1.12
Biological effects of clinically relevant wear particles from metal-on-metal hip prostheses. Proc Inst Mech Eng H (2006) 1.12
Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty (2004) 1.08
Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/macrophage activation in vitro. J Biomed Mater Res A (2003) 1.08
Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br (1999) 1.08
The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum (2006) 1.08
The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res (2005) 1.07
Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res (2002) 1.07
Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res (2003) 1.05
The influence of molecular weight, crosslinking and counterface roughness on TNF-alpha production by macrophages in response to ultra high molecular weight polyethylene particles. Biomaterials (2004) 1.03
Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am (2001) 1.02
Macrophage response to cross-linked and conventional UHMWPE. Biomaterials (2003) 1.00
Macrophage activation results in bone resorption. Clin Orthop Relat Res (1998) 0.97
Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A (2006) 0.97
Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am (2007) 0.97
RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res (2003) 0.97
Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays. J Biomed Mater Res A (2008) 0.97
The cytotoxic effect of titanium particles phagocytosed by osteoblasts. J Biomed Mater Res (1999) 0.95
Particulate endocytosis mediates biological responses of human mesenchymal stem cells to titanium wear debris. J Orthop Res (2006) 0.94
Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am (1997) 0.92
Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res (2003) 0.92
Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res (2003) 0.91
Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J Rheumatol (2005) 0.89
Pharmacologic modulation of periprosthetic osteolysis. Clin Orthop Relat Res (2005) 0.88
G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro. J Biomed Mater Res (2000) 0.87
Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro. J Orthop Res (2001) 0.87
Variation in the secreted frizzled-related protein-3 gene and risk of osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res (2007) 0.86
Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol (1997) 0.86
Orthopedic implant particle-induced tumor necrosis factor-alpha production in macrophage-monocyte lineage cells is mediated by nuclear factor of activated T cells. Ann N Y Acad Sci (2007) 0.85
Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res (1996) 0.85
Alterations in the adhesion behavior of osteoblasts by titanium particle loading: inhibition of cell function and gene expression. Biorheology (2001) 0.85
Kinetics of polymethylmethacrylate particle-induced inhibition of osteoprogenitor differentiation and proliferation. J Orthop Res (2007) 0.85
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials (2005) 0.85
Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers. J Bone Joint Surg Am (2007) 0.84
Cemented versus cementless hip arthroplasty. A review of prosthetic biocompatibility. Acta Orthop Scand (1992) 0.84
Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab (2004) 0.83
Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation. J Biomed Mater Res B Appl Biomater (2005) 0.82
Polymethylmethacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J Biomed Mater Res A (2006) 0.82
Periprosthetic microvasculature in loosening of total hip replacement. Arch Orthop Trauma Surg (1996) 0.82
Integrin expression at the bone/biomaterial interface. J Biomed Mater Res (2001) 0.80
ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3.E1 murine calvarial preosteoblastic cells. Ann N Y Acad Sci (2007) 0.79
Mast cells in loosening of totally replaced hips. Clin Orthop Relat Res (1996) 0.78
Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum (2008) 2.26
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Coronal and sagittal plane correction in adolescent idiopathic scoliosis: a comparison between all pedicle screw versus hybrid thoracic hook lumbar screw constructs. Spine (Phila Pa 1976) (2007) 1.68
A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet (2011) 1.60
Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas. J Bone Joint Surg Am (2011) 1.44
Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop Relat Res (2004) 1.41
Direct plain radiographic methods versus EBRA-Digital for measuring implant migration after total hip arthroplasty. J Arthroplasty (2002) 1.24
Accuracy of joint aspiration for the preoperative diagnosis of infection in total hip arthroplasty. J Arthroplasty (2006) 1.18
Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res (2005) 1.10
The effect of genome-wide association scan quality control on imputation outcome for common variants. Eur J Hum Genet (2011) 1.04
What other biologic and mechanical factors might contribute to osteolysis? J Am Acad Orthop Surg (2008) 1.04
What potential biologic treatments are available for osteolysis? J Am Acad Orthop Surg (2008) 1.01
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol (2014) 1.00
Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation. PLoS One (2013) 1.00
Regulation of nitric oxide and bcl-2 expression by shear stress in human osteoarthritic chondrocytes in vitro. J Cell Biochem (2003) 0.95
How has the biologic reaction to wear particles changed with newer bearing surfaces? J Am Acad Orthop Surg (2008) 0.94
What experimental approaches (eg, in vivo, in vitro, tissue retrieval) are effective in investigating the biologic effects of particles? J Am Acad Orthop Surg (2008) 0.92
Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite. J Bone Joint Surg Am (2008) 0.89
Metal-on-metal hip prostheses: where are we now? BMJ (2012) 0.89
Statistical shape and appearance models in osteoporosis. Curr Osteoporos Rep (2014) 0.89
Flexor tendon tissue engineering: bioreactor cyclic strain increases construct strength. Tissue Eng Part A (2010) 0.89
Are there biological markers of wear? J Am Acad Orthop Surg (2008) 0.88
Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages. Cell Signal (2011) 0.88
Zoledronate induces apoptosis in cells from fibro-cellular membrane of unicameral bone cyst (UBC). J Orthop Res (2005) 0.87
No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls. Ann Rheum Dis (2012) 0.86
A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation. PLoS One (2013) 0.82
Nuclear factor of activated T cells mediates fluid shear stress- and tensile strain-induced Cox2 in human and murine bone cells. Bone (2009) 0.80
Cannabinoids: novel therapies for arthritis? Future Med Chem (2012) 0.80
Understanding the tissue effects of tribo-corrosion: uptake, distribution, and speciation of cobalt and chromium in human bone cells. J Orthop Res (2014) 0.78
Mechanical loading differentially regulates membrane-bound and soluble RANKL availability in MC3T3-E1 cells. Ann N Y Acad Sci (2006) 0.78
Use of the Sheffield telescopic intramedullary rod system for the management of osteogenesis imperfecta: clinical outcomes at an average follow-up of nineteen years. J Bone Joint Surg Am (2011) 0.78
Magnetic resonance imaging depiction of tight iliotibial band in melorheostosis associated with severe external rotation deformity, limb shortening and patellar dislocation in planning surgical correction. Skeletal Radiol (2001) 0.77
Precision of periprosthetic bone mineral density measurements using Hologic Windows versus DOS-based analysis software. J Clin Densitom (2006) 0.77
Proteomic identification of 14-3-3ϵ as a linker protein between pERK1/2 inhibition and BIM upregulation in human osteosarcoma cells. J Orthop Res (2014) 0.76
High-spatial-resolution bone densitometry with dual-energy X-ray absorptiometric region-free analysis. Radiology (2014) 0.76
Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and post-total hip arthroplasty osteolysis. Arthritis Rheum (2009) 0.75
Effect of lower limb Sofield procedure on ambulation of osteogenesis imperfecta. J Pediatr Orthop (2002) 0.75
High-spatial-resolution bone densitometry with dual-energy X-ray absorptiometric region-free analysis. Radiology (2015) 0.75